The private sector and HIV/AIDS in Africa: Taking stock of 6 years of applied research

AIDS

Volumn 21, Issue SUPPL. 3, 2007, Pages

  Rosen, Sydney ^a,b   Feeley, Frank ^a   Connelly, Patrick ^a   Simon, Jonathon ^a  

^a BOSTON UNIVERSITY   (United States)

^b HELEN JOSEPH HOSPITAL   (South Africa)

Author keywords

Africa; HIV AIDS; Private sector

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; APPLIED RESEARCH; ARTICLE; DATA ANALYSIS; EMPLOYEE; ETHIOPIA; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; RWANDA; SOUTH AFRICA; UGANDA; WORKPLACE; ZAMBIA;

AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; COMMERCE; COSTS AND COST ANALYSIS; DATA COLLECTION; DATABASES, FACTUAL; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; OCCUPATIONAL HEALTH SERVICES; PRIVATE SECTOR; WORKPLACE;

EID: 34547663196     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000279693.61652.2d     Document Type: Article

References (40)

1. UNAIDS. 2006 Report on the global AIDS epidemic. Geneva: UNAIDS; 2006.
2. Haacker M. The macroeconomics of HIV/AIDS. Washington, DC: International Monetary Fund; 2004.
3. Barnett T, Whiteside A. AIDS in the twenty-first century: disease and globalization. New York: Palgrave MacMillan; 2002.
4. AIDSCAP Project. African workplace profiles. Washington, DC: Family Health International; 1995.
5. Quattek K, Fourie T. The economic impact of AIDS in South Africa: a dark cloud on the horizon. London: ING Barings; 2000.
6. Guinness L, Walker D, Ndubani P, Jama J, Kelly P. Surviving the impact of HIV-related illness in the Zambian business sector. AIDS Patient Care STDS 2003; 17:353-363.
7. Greener R. Impact of HIV/AIDS and options for intervention: results of a five company pilot study. Working paper no. 10. Gaborone: Botswana Institute of Development Policy Analysis; August 1997.
8. Biggs T, Shah M. The impact of the AIDS epidemic on African firms. Washington, DC: The World Bank; 1997.
9. Liu GG, Guo JJ, Smith SR. Economic costs to business of the HIV/AIDS epidemic. Pharmacoeconomics 2004; 22:1181-1194.
10. World Economic Forum. Case study library. Geneva: Global Health Initiative of the World Economic Forum; 2007. Available at: http://www.weforum. org/en/initiatives/globalhealth/Case% 20Study%20Library/index.htm. Accessed: 24 January 2007.
11. Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria. Interactive company case studies database. New York: Global Business Coalition on HIV/AIDS, Tuberculosis, and Malaria; 2007. Available at: http://www. businessfightsaids.org/site/pp.asp?c=gwKXJfNVJtF&b=1008921. Accessed: 24 January 2007.
12. Bloom DE, Bloom LR, Steven D, Weston M. Business and HIV/AIDS: a healthier partnership? Geneva: World Economic Forum; 2006. Available at: http://www.weforum.org/pdf/Initiatives/gbs2006_report.pdf. Accessed: 24 January 2007.
13. Ellis L, Terwin J. The impact of HIV/AIDS on selected business sectors in South Africa. Cape Town, South Africa: Bureau for Economic Research; 2005. Available at: http://www.ber.sun.ac.za/downloads/2005/aids/HIVAIDS_Report2005. pdf. Accessed: 24 January 2007.
14. Health Gap. AIDS activists protest Coke's deadly neglect of workers with AIDS in developing countries (press release). Barcelona, Spain: Health Gap Global Access Project; 10 July 2002. Available at: http://www.healthgap.org/ press_releases/02/071002_HGAP_PR_COKE_BCN.html. Accessed: 24 April 2006.
15. Global Business Coalition on HIV/AIDS. Business action on HIV now crucial, as AIDS crisis deepens (press release). New York: Global Business Council on HIV/AIDS; 30 November 2001. Available at: http://www. businessfightsaids.org/site/apps/nl/content2.asp?c=gwKXJfNVJtF&b= 1008911&ct=1366121. Accessed: 24 April 2006.
16. Rosen S, Simon JL. Shifting the burden: the private sector's response to the AIDS epidemic in Africa. Bull WHO 2003; 81:131-137.
17. Rosen S, Vincent JR, MacLeod W, Fox M, Thea DM, Simon JL. The cost of HIV/AIDS to businesses in southern Africa. AIDS 2004; 18:317-324.
18. Connelly P, Rosen S. Will small and medium enterprises provide HIV/AIDS services to employees? An analysis of market demand. S Afr J Econ 2005; 73:613-626.
19. Feeley R, Bukuluki P, Collier A, Fox MP. The impact of HIV/AIDS on productivity and labor costs in two Ugandan corporations. Boston, MA: Center for International Health and Development, Boston University; 2004.
20. Rosen S, Hamazakaza P, Long L. The impact of HIV/AIDS on the tourism sector in Zambia. Boston, MA: Center for International Health and Development, Boston University; 2005.
21. Rosen S, Hamazakaza P, Long L. HIV/AIDS in the commercial agriculture sector in Zambia: impact and responses. Boston, MA: Center for International Health and Development, Boston University; 2006.
22. Rosen S, Bii M, Long L, Fox MP. HIV/AIDS in the commercial agriculture sector in Kenya: impact and responses. Boston, MA: Center for International Health and Development, Boston University; 2005.
23. Fox MP, Rosen S, MacLeod WB, Wasunna M, Bii M, Foglia G, et al. The impact of HIV/AIDS on labor productivity in Kenya. Trop Med Int Health 2004; 9:318-324.
24. Van der Borght S, Richards S, Rinke de Wit T, Collier A, Fox MP, Feeley R. A successful workplace program for VCT and HAART at Heineken, Rwanda. Int J Environ Occup Health 2007; 13:99-106.
25. Feeley R. Employer costs related to HIV infection and a comparison to the costs of AIDS treatment and prevention. Addis Ababa, Ethiopia: PSP Ethiopia; 2005.
26. Connelly P, Rosen S. Opportunities to expand HIV/AIDS services to employees of small and medium-sized companies in Wynberg, South Africa. Boston, MA: Center for International Health and Development, Boston University; 2005.
27. Connelly P, Rosen S. Treatment for HIV/AIDS at South Africa's largest employers: myth and reality. S Afr Med J 2006; 96:128-133.
28. Feeley R, Bukuluki P, Cowley P. The role of the private sector in preventing and treating HIV/AIDS in Uganda: an assessment of current activities and the outlook for future action. Boston, MA: Center for International Health and Development, Boston University; 2004.
29. Lall S. Strengthening SMEs for international competitiveness. Workshop on What Makes Your Firm Internationally Competitive. Egyptian Centre for Economic Studies Cairo, Egypt. 6-8 March 2000. Available at: http://www.worldbank.org/wbi/mdf/mdf3/papers/firm/Lall.pdf. Accessed: 24 April 2006.
30. Beck T, Demirguk-Kunt A, Levine R. SMEs, growth, and poverty: cross-country evidence. Working paper 11224. Cambridge: National Bureau of Economic Research; 2005. Available at: http://www.nber.org/papers/W11224. Accessed: 24 April 2006.
31. Ntsika Enterprise Promotion Agency. State of small business development in South Africa. Annual review 2002. Pretoria, South Africa: Ntsika Enterprise Promotion Agency; 2002.
32. Evian C, Fox M, MacLeod W, Slotow SJ, Rosen S. Prevalence of HIV in workforces in southern Africa, 2000-2001. S Afr Med J 2004; 94:125-130.
33. Connelly P, Rosen S. Can small and medium enterprises in South Africa provide HIV/AIDS services to their employees? A market analysis. Boston, MA: Center for International Health and Development, Boston University; 2004.
34. Corbett EL, Makamure B, Cheung YB, Dauya E, Matambo R, Bandason T, et al. HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS 2007; 21:483-489.
35. Sterne JA, Hernan MA, Ledergerber B, Tilling K, Weber R, Sendi P, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366:378-384.
36. Marins JR, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS 2003; 17:1675-1682.
37. Bekker LG, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J 2006; 96:315-322.
38. Laurent C, Ngom Gueye NF, Ndour CT, Gueye PM, Diouf M, Diakhate N, et al. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr 2005; 38:14-17.
39. Wester CW, Kim S, Bussmann H, Avalos A, Ndwapi N, Peter TF, et al. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr 2005; 40:336-343.
40. Brink B. An interim appraisal of the Anglo American AIDS treatment programme. Plenary Session, 10 June 2007. 2nd South African AIDS Conference, Durban, South Africa, 7-10 June 2005.